Isolation and analysis of tumor-derived exosomes and microvesicles from body fluids. Reveals tumor biology and may predict treatment response.
Manufactured by
Guangdong Guangzhou, China
Burning Rock Dx (NASDAQ: BNR) is a global precision oncology leader specializing in NGS-based diagnostics for both tissue and liquid biopsy. With internationally accredited labs (CLIA, CAP, ISO15189, ISO13485) and deep NGS expertise, the company offers a broad portfolio of in-house assays and integrated solutions across the oncology development cycle. Burning Rock supports pharmaceutical development and decentralized clinical implementation, partnering with biopharma and clinical labs to advance trials, biomarker research, and real-world diagnostics. Key milestones include two NMPA-approved IVD kits, four CE-marked assays, and Breakthrough Device Designations from both the FDA and NMPA for its multi-cancer early detection test. Burning Rock is committed to transforming cancer care through innovative, science-driven solutions. In addition to the CLIA / CAP laboratory in the United States, we have a CLIA / CAP / ISO 15189 / ISO13485 lab in Guangzhou, China, which also obtained the technical certification of “High-throughput sequencing laboratory” issued by the Guangdong Center for Clinical Laboratory. We have passed over 200 inter-laboratory quality evaluations organized by NCCL, PQCC, EMQN, CAP, and other authoritative organizations.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Beijing Hotgen Biotech Co.,Ltd
China · 2 relevant products
Jiangsu Avatarget Biotechnology Limited Liability Company
China · 1 relevant product
Axbio (shenzhen) Co.,LTD
China · 1 relevant product
U-GEN BIOTECHNOLOGY INC.
China · 1 relevant product
CheMOnitor Ltd.
Hungary · 1 relevant product
Qingdao Raisecare Biological Technology Co., Ltd.
China · 1 relevant product
NANJING NANOEAST BIOTECH CO.,LTD
China · 1 relevant product
S&T BioMed CO., LTD.
Taiwan · 2 relevant products
guangzhou biotron technolongy co.,ltd
China · 3 relevant products
Biopsense Oy
Finland · 3 relevant products
35 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →2 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 60 closest product alternatives
Beijing Hotgen Biotech Co.,Ltd · China
Diagnostic products for extracellular vesicle detection and analysis. Used for biomarker assessment in liquid biopsy and disease diagnostics.
Jiangsu Avatarget Biotechnology Limited Liability Company · China
Clinical service for personalized cancer drug response evaluation using patient-derived tumor organoids and organ chips. Supports precision medicine treatment selection and optimization.
Axbio (shenzhen) Co.,LTD · China
Molecular diagnostic kit for cancer genomics profiling and tumor mutation analysis. Enables detection of somatic mutations relevant to oncology and cancer treatment planning.
U-GEN BIOTECHNOLOGY INC. · China
Proprietary circulating tumor DNA analysis platform offering high accuracy and sensitivity for early cancer detection. Provides precision diagnosis for personalized cancer management and monitoring.
CheMOnitor Ltd. · Hungary
Early diagnostic solution for monitoring chemotherapy effectiveness in lung cancer patients at an initial treatment stage. Uses glycan analysis to predict treatment response and enable timely clinical decision-making.
Qingdao Raisecare Biological Technology Co., Ltd. · China
Advanced diagnostic test for measuring and analyzing immunological biomarkers in patient samples. Supports precise immune assessment to enable targeted therapeutic pathways and improved clinical outcomes.
NANJING NANOEAST BIOTECH CO.,LTD · China
Specialized magnetic particles for isolation of exosomes from biological fluids. Support biomarker discovery and diagnostic analysis of circulating extracellular vesicles.
S&T BioMed CO., LTD. · Taiwan
A blood exosome detection kit for screening pancreatic cancer and cholangiocarcinoma. This diagnostic kit applies magneto-electrochemical detection technology and protein biomarker analysis for cancer identification.
guangzhou biotron technolongy co.,ltd · China
Advanced liquid biopsy system for non-invasive detection and analysis of circulating tumor markers, circulating tumor cells, and cell-free DNA from blood samples.
Biopsense Oy · Finland
Liquid biopsy diagnostic solution for non-invasive cancer monitoring and treatment personalization through cell-free DNA analysis. Automates plasma separation, DNA extraction, and quantitation to reduce pre-analytical variability and enable frequent patient monitoring for improved treatment response assessment.
Biopsense Oy · Finland
Blood-based diagnostic test for monitoring cancer treatment efficacy and detecting emerging drug resistance through analysis of circulating tumor DNA. Enables rapid treatment adjustment decisions based on genetic mutation detection in cfDNA.
Bio-Techne Diagnostics · United States
Advanced molecular assays for liquid biopsy applications enabling non-invasive detection of circulating biomarkers. Integrated with automated analysis for scalable clinical implementation.
48 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products